Cancer-Associated Thrombosis: Risk Assessment, Prevention, and Treatment.

Authors :: Halsema K
Mcmahon B
Source :: Journal of the advanced practitioner in oncology [J Adv Pract Oncol] 2023 Apr; Vol. 14 (3), pp. 213-217. Date of Electronic Publication: 2023 Apr 01.
Publication Year :: 2023
Abstract: The risk of developing venous thromboembolism (VTE) is four to seven times higher in patients with cancer than in those without. At JADPRO Live 2022, presenters discussed risk factors and assessing patients for VTE, as well as how to protect patients against VTE in both the inpatient and outpatient clinic settings. They reviewed selecting an appropriate anticoagulation treatment, including the choice of agent and duration of treatment for the patient with cancer, and finally the steps needed to assess and treat patients experiencing therapeutic anticoagulation failure.<br />Competing Interests: Ms. Halsema has no relevant financial relationships to disclose. Dr. McMahon has served as a consultant for CTI Biopharma and Curio Science.<br /> (© 2023 Harborside™.)